Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: Implications for the process of drusen formation

American Journal of Ophthalmology

Volumn 131, Issue 6, 2001, Pages 767-781

  Anderson, Don H ^a   Ozaki, Shiro ^a   Nealon, Matthew ^a   Neitz, Jay ^b   Mullins, Robert F ^c   Hageman, Gregory S ^c   Johnson, Lincoln V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EYE INSTITUTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; MESSENGER RNA;

ADOLESCENT; ADULT; AGE; AGED; ALLELE; ARTICLE; BRUCH MEMBRANE; CELL TYPE; CHOROID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUSEN; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREACTIVITY; INHERITANCE; PATHOGENESIS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RETINA GANGLION CELL; RETINA MACULA DEGENERATION; RETINA NEUROEPITHELIAL LAYER;

ADULT; AGED; APOLIPOPROTEINS E; BRUCH MEMBRANE; CELLS, CULTURED; CHOROID; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICROSCOPY, CONFOCAL; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; RETINA; RETINAL DRUSEN; RNA, MESSENGER; ROD OUTER SEGMENTS; TISSUE DISTRIBUTION;

EID: 0035008434     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00961-2     Document Type: Article

References (25)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
2. Gliemann J. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. Biol Chem 1998;379:951-964.
3. Mahley RW, Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol 1999;10:207-217.
4. Davignon J, Cohn HS, Mabile L, Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 1999;286:115-143.
5. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
6. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995;92:4725-4727.
7. Pauleikhoff D, Barondes M, Minassian D, et al. Drusen and their significance in age related macular degeneration. Fortschr Ophthalmol 1990;87:429-432.
8. Souied EH, Benlian P, Amouyel P, et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998;125:353-359.
9. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration [published erratum appears in Am J Hum Genet 1998;63:1252]. Am J Hum Genet 1998;63:200-206.
10. Pauleikhoff D, Zuels S, Sheraidah GS, et al. Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. Ophthalmology 1992;99:1548-1553.
11. Farkas TG, Sylvester V, Archer D, Altona M. The histochemistry of drusen. Am J Ophthalmol 1971;71:1206-1215.
12. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 2001;42:265-274.
13. Mullins RF, Johnson LV, Anderson DH, Hageman GS. Characterization of drusen-associated glycoconjugates. Ophthalmology 1997;104:288-294.
14. Russell SR, Mullins RF, Schneider BL, Hageman GS. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol 2000;129:205-214.
15. Fariss RN, Apte SS, Olsen BR, Iwata K, Milam AH. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J Pathol 1997;150:323-328.
16. Newsome DA, Hewitt AT, Huh W, Robey PC, Hassell JR. Detection of specific extracellular matrix molecules in drusen, Bruch's membrane, and ciliary body. Am J Ophthalmol 1987;104:373-381.
17. Hageman GS, Mullins RF, Clark WG, Johnson LV, Anderson DH. Drusen share molecular constituents common to atherosclerotic, elastotic and amyloid deposits. Invest Ophthalmol Vis Sci 1995;36:S432.
18. Hageman GS, Mullins RF, Johnson LV, Anderson DH. Cell biology of AMD: analyses of age-related extracellular deposits. Invest Ophthalmol Vis Sci 1996;37:S450.
19. Anderson D, Hageman G, Mullins R, et al. Local cellular sources of drusen-associated molecules. Invest Ophthalmol Vis Sci 1998;39(suppl):369.
20. Sarks SH, Sarks JP. Age-related macular degeneration: atrophic form. In: Schachat AP and Murphy RB, editors. Medical retina. St. Louis: Mosby, 1994:1071-1102.
21. Johnson L, Ozaki S, Staples M, Erickson P, Anderson D. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 2000;40:441-449.
22. Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J 1999;13:477-484.
23. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000;14:835-846.
24. Chao YS, Yamin TT, Thompson GM, Kroon PA. Tissue-specific expression of genes encoding apolipoprotein E and apolipoprotein A-I in rabbits. J Biol Chem 1984;259:5306-5309.
25. Seiffert D, Crain K, Wagner NV, Loskutoff DJ. Vitronectin gene expression in vivo. Evidence for extrahepatic synthesis and acute phase regulation. J Biol Chem 1994;269:19836-19842.